GT Biopharma Inc (GTBP)

[scoot27]

I don't see how it would be possible for this stock to be listed on the Nasdaq with no profits, check that no revenue. My opinion is they are trying to get a bump in the stock price. I think (not 100% sure) I read that stock that was converted from debt can only be sold at $7/share or higher for a specified time period. Since most of the outstanding stock is from the convertible debt there isn't much out there for retail sale, that is the only thing in my opinion keeping the share price where it is. I believe once the sale restrictions are gone for the people that converted their debt, this stock will be back below the $1.

This Is my opinion only and not based on fact in anyway. Just believe you should always be wary of a company with no revenue and a likely a year or two away from even possibly earning revenue.